NEW YORK, March 3, 2015 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AAC Holdings, Inc. ("AAC" or the "Company") (NYSE: AAC).  Such investors are advised to contact Robert S. Willoughby at rswilloughby@pomlaw.com or 888-476-6529, ext. 237.

The investigation concerns whether AAC and certain of its officers and/or directors have violated Sections 10(b) and 20(a) of the Securities Exchange Act of 1934. 

On March 3, 2015, SeekingAlpha published an article alleging that AAC has inflated its revenues and margins by conducting medically unnecessary urine testing. Additionally, the article alleges that AAC has boosted its net income by inappropriately changing the methodology by which it calculates its provision for doubtful accounts receivable. 

On this news, shares of AAC fell $3.54 per share to $30.73, or more than 10.33%, in intraday trading on March 3, 2015.

The Pomerantz Firm, with offices in New York, Chicago, San Diego and Florida, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 70 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com.

CONTACT:
Robert S. Willoughby
Pomerantz LLP
rswilloughby@pomlaw.com 

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shareholder-alert-pomerantz-law-firm-investigates-claims-on-behalf-of-investors-of-aac-holdings-inc--aac-300045150.html

SOURCE Pomerantz LLP